https://www.avient.com/sites/default/files/2021-06/avient-inscripcion-por-cambio-de-denominacion.pdf
https://www.avient.com/sites/default/files/2024-02/AVNT Q4 2023 Earnings Press Release.pdf
Rose
Vice President, Marketing and Communications
Avient Corporation
+1 440-930-3162
kyle.rose@avient.com
mailto:giuseppe.disalvo@avient.com
mailto:kyle.rose@avient.com
6
Attachment 1
Avient Corporation
Summary of Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
Three Months Ended
December 31,
Year Ended
December 31,
2023 2022 2023 2022
Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9
Operating income 43.1 0.4 196.8 243.3
Net income (loss) from continuing operations attributable to Avient
shareholders 27.8 (17.0) 75.8 82.8
Diluted earnings (loss) per share from continuing operations attributable
$ 0.30 $ (0.19) $ 0.83 $ 0.90
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
Three Months Ended
December 31,
Year Ended
December 31,
Reconciliation to Consolidated Statements of Income 2023 2022 2023 2022
Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9
Gross margin - GAAP 208.9 172.0 892.5 882.7
Special items in gross margin (Attachment 3) 17.6 45.5 80.0 81.1
Adjusted gross margin $ 226.5 $ 217.5 $ 972.5 $ 963.8
Adjusted gross margin as a percent of sales 31.5 % 27.5 % 30.9 % 28.4 %
Operating income - GAAP 43.1 0.4 196.8 243.3
Special items in operating income (Attachment 3) 26.1 59.9 116.0 108.7
Adjusted operating income $ 69.2 $ 60.3 $ 312.8 $ 352.0
Adjusted operating income as a percent of sales 9.6 % 7.6 % 10.0 % 10.4 %
The following pro forma adjustments are referenced by management to provide comparable business performance by
incorporating the APM business in periods prior to the acquisition date (September 1, 2022).
Three Months Ended Year Ended
Reconciliation of Pro Forma Adjusted Earnings per Share December 31, 2022
Net (loss) income from continuing operations attributable to Avient
shareholders $ (17.0) $ 82.8
Special items, after tax (Attachment 3) 38.3 116.2
Amortization expense, after-tax (Attachment 1) 14.6 49.0
Adjusted net income from continuing operations excluding special items 35.9 248.0
APM pro forma adjustments to net income from continuing operations* 2.5 13.6
APM amortization expense, after tax* — 19.1
Pro forma adjusted net income from continuing operations attributable to Avient
shareholders $ 38.4 $ 280.7
Weighted average diluted shares 91.7 92.2
Pro forma adjusted EPS - excluding special items $ 0.42 $ 3.04
* Pro forma adjustment for January - August 2022 APM results (period before Avient ownership) including the impacts of debt financing and
prepayments on net income from continuing operations.
14
Free Cash Flow Calculation December 31, 2023
Cash provided by operating activities $ 201.6
Taxes paid on gain on sale of business 104.1
Adjusted cash provided by operating activities $ 305.7
Capital expenditures $ (119.4)
Free cash flow $ 186.3
Three Months Ended
March 31, 2023
Reconciliation to Condensed Consolidated Statements of Income $ EPS
Net income from continuing operations attributable to Avient shareholders $ 20.8 $ 0.23
Special items, after tax 22.3 0.24
Amortization expense, after-tax 15.1 0.16
Adjusted net income / EPS $ 58.2 $ 0.63
Three Months Ended
December 31,
Year Ended
December 31,
Reconciliation to EBITDA and Pro Forma Adjusted EBITDA 2023 2022 2023 2022
Net income (loss) from continuing operations – GAAP $ 27.6 $ (16.6) $ 76.3 $ 83.1
Income tax (benefit) expense (7.0) (60.8) 11.0 (19.3)
Interest expense 26.8 49.4 115.3 119.8
Depreciation and amortization from continuing operations 44.2 48.6 188.8 162.5
EBITDA from continuing operations $ 91.6 $ 20.6 $ 391.4 $ 346.1
Special items, before tax 22.4 104.3 114.6 194.0
Interest expense included in special items (0.1) (16.0) (2.3) (26.0)
Depreciation and amortization included in special items — (1.5) (1.9) (5.5)
Adjusted EBITDA $ 113.9 $ 107.4 $ 501.8 $ 508.6
APM pro forma adjustments - 8 months 2022* — — — 83.1
Pro forma adjusted EBITDA $ 113.9 $ 107.4 $ 501.8 $ 591.7
* Pro forma adjustment for January - August 2022 APM results (period before Avient ownership).
https://www.avient.com/investor-center/news/avient-provides-fourth-quarter-2020-updates
Pro forma for the acquisition of Clariant Masterbatch, the company noted sales for October and November increased 5.4% over the same months in the prior year.
Three Months Ended
https://www.avient.com/sites/default/files/2022-09/Avient Discontinued Operations Financial Information.pdf
G A A P I N C O M E S T A T E M E N T R E C A S T F O R A V I E N T D I S T R I B U T I O N A S A
D I S C O N T I N U E D O P E R A T I O N
Avient Corporation 3
(In millions, except per share data)
Q1 2021 Q2 2021 Q3 2021 Q4 2021 2021 YTD Q1 2022 Q2 2022 YTD 2022
Sales 826.0$ 864.5$ 818.0$ 807.1$ 3,315.6$ 892.2$ 891.0$ 1,783.2$
Cost of sales 562.9 615.9 602.4 590.5 2,371.7 637.8 630.1 1,267.9
Gross margin 263.1 248.6 215.6 216.6 943.9 254.4 260.9 515.3
Selling and administrative 168.7 166.2 162.8 166.4 664.1 152.2 160.8 313.0
Operating income 94.4 82.4 52.8 50.2 279.8 102.2 100.1 202.3
Interest expense, net (19.3) (19.5) (19.0) (17.5) (75.3) (16.9) (16.2) (33.1)
Other income (expense), net 1.6 1.1 1.6 (5.3) (1.0) (0.6) 1.6 1.0
Income before income taxes 76.7 64.0 35.4 27.4 203.5 84.7 85.5 170.2
Income tax (expense) benefit (16.3) (13.8) (2.0) (16.2) (48.3) (20.0) (22.7) (42.7)
Net income from continuing operations 60.4 50.2 33.4 11.2 155.2 64.7 62.8 127.5
Net income from discontinued operations, net of income taxes 19.3 19.2 19.2 17.7 75.4 19.8 21.9 41.7
Net income 79.7 69.4 52.6 28.9 230.6 84.5 84.7 169.2
Net (income) loss attributable to noncontrolling interests (0.4) (0.6) 0.3 0.9 0.2 (0.3) - (0.3)
Net income attributable to Avient common shareholders 79.3$ 68.8$ 52.9$ 29.8$ 230.8$ 84.2$ 84.7$ 168.9$
Earnings per share attributable to Avient common shareholders - Basic
Continuing operations 0.66$ 0.54$ 0.37$ 0.13$ 1.70$ 0.70$ 0.69$ 1.39$
Discontinued operations 0.21$ 0.21$ 0.21$ 0.20$ 0.83$ 0.22$ 0.24$ 0.46$
Total 0.87$ 0.75$ 0.58$ 0.33$ 2.53$ 0.92$ 0.93$ 1.85$
Earnings per share attributable to Avient common shareholders - Diluted
Continuing operations 0.65$ 0.54$ 0.37$ 0.13$ 1.69$ 0.70$ 0.68$ 1.38$
Discontinued operations 0.21$ 0.20$ 0.20$ 0.19$ 0.82$ 0.21$ 0.24$ 0.45$
Total 0.86$ 0.74$ 0.57$ 0.32$ 2.51$ 0.91$ 0.92$ 1.83$
A D J U S T E D F I N A N C I A L I N F O R M A T I O N R E C A S T F O R A V I E N T D I S T R I B U T I O N A S A
D I S C O N T I N U E D O P E R A T I O N
Avient Corporation 4
(In millions, except per share data)
Q1 2021 Q2 2021 Q3 2021 Q4 2021 2021 YTD Q1 2022 Q2 2022 YTD 2022
Sales 826.0$ 864.5$ 818.0$ 807.1$ 3,315.6$ 892.2$ 891.0$ 1,783.2$
Cost of sales 565.1 603.3 585.1 584.6 2,338.1 632.0 632.1 1,264.1
Gross margin 260.9 261.2 232.9 222.5 977.5 260.2 258.9 519.1
Selling and administrative 164.1 164.6 160.1 161.1 649.9 151.3 157.0 308.3
Operating income 96.8 96.6 72.8 61.4 327.6 108.9 101.9 210.8
Interest expense, net (19.3) (19.5) (19.0) (17.5) (75.3) (16.9) (16.2) (33.1)
Other income (expense), net 1.6 1.1 1.5 4.1 8.3 (0.7) 0.7 0.0
Income before income taxes 79.1 78.2 55.3 48.0 260.6 91.3 86.4 177.7
Income tax expense (16.1) (16.3) (10.2) (12.8) (55.4) (20.2) (20.4) (40.6)
Net income from continuing operations 63.0 61.9 45.1 35.2 205.2 71.1 66.0 137.1
Net (income) loss attributable to noncontrolling interests
(0.4) (0.6) 0.3 0.9 0.2 (0.3) - (0.3)
Adjusted Net income attributable to Avient common
shareholders - continuing operations 62.6$ 61.3$ 45.4$ 36.1$ 205.4$ 70.8$ 66.0$ 136.8$
Adjusted earnings per share attributable to Avient
common shareholders - Diluted 0.68$ 0.66$ 0.49$ 0.39$ 2.23$ 0.77$ 0.72$ 1.48$
Weighted average diluted Shares 92.2 92.4 92.2 92.4 92.1 92.3 92.1 92.2
S E G M E N T D A T A R E C A S T F O R A V I E N T D I S T R I B U T I O N A S A D I S C O N T I N U E D
O P E R A T I O N
Avient Corporation 5
(In millions)
Q1 2021 Q2 2021 Q3 2021 Q4 2021 2021 YTD Q1 2022 Q2 2022 2022 YTD
Sales:
Color, Additives and Inks 609.3$ 624.4$ 586.6$ 581.3$ 2,401.6$ 649.5$ 649.1$ 1,298.6$
Specialty Engineered Materials 214.7 238.9 231.7 226.3 911.6 243.1 242.3 485.4
Corporate and Eliminations 2.0 1.2 (0.3) (0.5) 2.4 (0.4) (0.4) (0.8)
Sales 826.0 864.5 818.0 807.1 3,315.6 892.2 891.0 1,783.2
Gross Margin:
Color, Additives and Inks 197.5$ 193.4$ 172.1$ 164.5$ 727.5$ 192.1$ 193.4$ 385.5$
Specialty Engineered Materials 63.1 68.1 61.4 58.3 250.9 68.4 66.0 134.4
Corporate and Eliminations 2.5 (12.9) (17.9) (6.2) (34.5) (6.1) 1.5 (4.6)
Gross Margin 263.1 248.6 215.6 216.6 943.9 254.4 260.9 515.3
Se lling and Administrative Expense :
Color, Additives and Inks 108.7$ 107.1$ 105.3$ 103.3$ 424.4$ 97.6$ 99.8$ 197.4$
Specialty Engineered Materials 30.5 32.3 31.4 31.2 125.4 30.1 30.8 60.9
Corporate and Eliminations 29.5 26.8 26.1 31.9 114.3 24.5 30.2 54.7
Selling and Administrative Expense 168.7 166.2 162.8 166.4 664.1 152.2 160.8 313.0
Operating Income:
Color, Additives and Inks 88.8$ 86.3$ 66.8$ 61.2$ 303.1$ 94.5$ 93.6$ 188.1$
Specialty Engineered Materials 32.6 35.8 30.0 27.1 125.5 38.3 35.2 73.5
Corporate and Eliminations (27.0) (39.7) (44.0) (38.1) (148.8) (30.6) (28.7) (59.3)
Operating Income 94.4 82.4 52.8 50.2 279.8 102.2 100.1 202.3
Earnings Be fore Interest, Taxes,
Depreciation and Amortization (EBITDA):
Color, Additives and Inks 116.2$ 111.6$ 93.4$ 87.6$ 408.8$ 120.5$ 119.5$ 240.0$
Specialty Engineered Materials 40.4 43.9 37.9 35.1 157.3 46.1 42.9 89.0
Corporate and Eliminations (25.3) (39.5) (41.9) (34.6) (141.3) (26.8) (26.0) (52.8)
Other income (expense) 1.6 1.1 1.6 (5.3) (1.0) (0.6) 1.6 1.0
EBITDA 132.9 117.1 91.0 82.8 423.8 139.2 138.0 277.2
N O N - G A A P R E C O N C I L I A T I O N S F O R R E C A S T H I S T O R I C A L R E S U L T S
Avient Corporation 6
(In millions, except per share data)
Avie nt
Special
Items
Adjuste d
Avient Avient
Special
Items
Adjusted
Avient Avient
Special
Items
Adjusted
Avient Avient
Special
Items
Adjusted
Avient Avient
Special
Items
Adjusted
Avie nt
Sales $ 826.0 $ - $ 826.0 $ 864.5 $ - $ 864.5 $ 818.0 $ - $ 818.0 $ 807.1 $ - $ 807.1 $ 3,315.6 $ - $ 3,315.6
Gross margin 263.1 (2.2) 260.9 248.6 12.6 261.2 215.6 17.3 232.9 216.6 5.9 222.5 943.9 33.6 977.5
Selling and administrative expense 168.7 (4.6) 164.1 166.2 (1.6) 164.6 162.8 (2.7) 160.1 166.4 (5.3) 161.1 664.1 (14.2) 649.9
Operating income 94.4 2.4 96.8 82.4 14.2 96.6 52.8 20.0 72.8 50.2 11.2 61.4 279.8 47.8 327.6
Interest expense, net (19.3) - (19.3) (19.5) - (19.5) (19.0) - (19.0) (17.5) - (17.5) (75.3) - (75.3)
Other income (expense), net 1.6 - 1.6 1.1 - 1.1 1.6 (0.1) 1.5 (5.3) 9.4 4.1 (1.0) 9.3 8.3
Income taxes (16.3) 0.2 (16.1) (13.8) (2.5) (16.3) (2.0) (8.2) (10.2) (16.2) 3.4 (12.8) (48.3) (7.1) (55.4)
Net income (loss) attributable to noncontrolling
interests
(0.4) - (0.4) (0.6) - (0.6) 0.3 - 0.3 0.9 - 0.9 0.2 - 0.2
Net income from continuing operations attributable
to Avient shareholders
$ 60.0 $ 2.6 $ 62.6 $ 49.6 $ 11.7 $ 61.3 $ 33.7 $ 11.7 $ 45.4 $ 12.1 $ 24.0 $ 36.1 $ 155.4 $ 50.0 $ 205.4
Net income / EPS $ 0.65 0.03 $ 0.68 $ 0.54 0.13 $ 0.66 $ 0.37 0.13 $ 0.49 $ 0.13 $ 0.26 $ 0.39 $ 1.69 0.54 $ 2.23
Weighted-average diluted shares 92.2 92.2 92.2 92.4 92.4 92.4 92.2 92.2 92.2 92.4 92.4 92.4 92.1 92.1 92.1
Three Months Ended
December 31, 2021
Year Ended
December 31, 2021
Three Months Ended
March 31, 2021
Three Months Ended
June 30, 2021
Three Months Ended
September 30, 2021
N O N - G A A P R E C O N C I L I A T I O N S F O R R E C A S T H I S T O R I C A L R E S U L T S
Avient Corporation 7
(In millions, except per share data)
Avient
Special
Items
Adjusted
Avient Avient
Special
Items
Adjusted
Avient Avient
Special
Items
Adjusted
Avient
Sales $ 892.2 $ - $ 892.2 $ 891.0 $ - $ 891.0 $ 1,783.2 $ - $ 1,783.2
Gross margin 254.4 5.8 260.2 260.9 (2.0) 258.9 515.3 3.8 519.1
Selling and administrative expense 152.2 (0.9) 151.3 160.8 (3.8) 157.0 313.0 (4.7) 308.3
Operating income 102.2 6.7 108.9 100.1 1.8 101.9 202.3 8.5 210.8
Interest expense, net (16.9) - (16.9) (16.2) - (16.2) (33.1) - (33.1)
Other (expense) income, net (0.6) (0.1) (0.7) 1.6 (0.9) 0.7 1.0 (1.0) 0.0
Income taxes (20.0) (0.2) (20.2) (22.7) 2.3 (20.4) (42.7) 2.1 (40.6)
Net income attributable to noncontrolling interests (0.3) - (0.3) - - - (0.3) - (0.3)
Net income from continuing operations attributable
to Avient shareholders
$ 64.4 $ 6.4 $ 70.8 $ 62.8 $ 3.2 $ 66.0 $ 127.2 $ 9.6 $ 136.8
Net income / EPS $ 0.70 0.07 $ 0.77 $ 0.68 0.03 $ 0.72 $ 1.38 0.10 1.48
Weighted-average diluted shares 92.3 92.3 92.3 92.1 92.1 92.1 92.2 92.2 92.2
Three Months Ended
March 31, 2022
Three Months Ended
June 30, 2022
Six Months Ended
June 30, 2022
N O N - G A A P R E C O N C I L I A T I O N S F O R R E C A S T A D J U S T E D E B I T D A
Avient Corporation 8
(In millions)
EBITDA Reconciliation Q1 2021 Q2 2021 Q3 2021 Q4 2021 YTD 2021 Q1 2022 Q2 2022 YTD 2022
Net income from continuing operations – GAAP 60.4$ 50.2$ 33.4$ 11.2$ 155.2$ 64.7$ 62.8$ 127.5$
Income tax expense 16.3 13.8 2.0 16.2 48.3 20.0 22.7 42.7
Interest expense, net 19.3 19.5 19.0 17.5 75.3 16.9 16.2 33.1
Depreciation and amortization from continuing operations 36.9 33.6 36.6 37.9 145.0 37.6 36.3 73.9
EBITDA 132.9 117.1 91.0 82.8 423.8 139.2 138.0 277.2
Special items, before tax 2.4 14.2 19.9 20.6 57.1 6.6 0.9 7.5
Depreciation and amortization included in special items (0.6) 1.4 (0.9) (1.6) (1.7) (2.1) (1.1) (3.2)
Adjusted EBITDA 134.7$ 132.7$ 110.0$ 101.8$ 479.2$ 143.7$ 137.8$ 281.5$
S U M M A R Y O F S P E C I A L I T E M S
Avient Corporation 9
(In millions)
Q1 2021 Q2 2021 Q3 2021 Q4 2021 2021 YTD Q1 2022 Q2 2022 2022 YTD
Cost of sales:
Restructuring costs, including accelerated depreciation (1.8)$ (1.5)$ (5.3)$ (6.0)$ (14.6)$ (4.4)$ (2.6)$ (7.0)$
Environmental remediation costs (0.5) (12.5) (9.4) (0.5) (22.9) (2.0) (3.0) (5.0)
Reimbursement of previously incurred environmental costs 4.5 - - - 4.5 0.6 7.6 8.2
Acquisition related adjustments - 1.4 (2.6) 0.6 (0.6) - - -
Impact on cost of sales 2.2 (12.6) (17.3) (5.9) (33.6) (5.8) 2.0 (3.8)
Selling and administrative expense:
Restructuring, legal and other (1.3) (1.4) - (4.2) (6.9) 2.0 (1.7) 0.3
Acquisition/divestiture related costs (3.3) (0.2) (2.7) (1.1) (7.3) (2.9) (2.1) (5.0)
Impact on selling and administrative expense (4.6) (1.6) (2.7) (5.3) (14.2) (0.9) (3.8) (4.7)
Impact on operating income (2.4) (14.2) (20.0) (11.2) (47.8) (6.7) (1.8) (8.5)
Other income, net - - 0.1 (9.4) (9.3) 0.1 0.9 1.0
Impact on income before income taxes (2.4) (14.2) (19.9) (20.6) (57.1) (6.6) (0.9) (7.5)
Income tax benefit on above special items 0.9 3.4 4.6 4.1 13.0 1.7 0.2 1.9
Tax adjustments (1.1) (0.9) 3.6 (7.5) (5.9) (1.5) (2.5) (4.0)
Impact of special items on net income (2.6)$ (11.7)$ (11.7)$ (24.0)$ (50.0)$ (6.4)$ (3.2)$ (9.6)$
https://www.avient.com/sites/default/files/2021-03/avient-antitrust-2021-update-czech-a4.pdf
Een Overzicht van de
1
Obsah Revidované antimonopolní zásady 2021
Amerikaanse Přehled
antimonopolních zákonů USA
Antimonopolní zákony USA mají široký dosah a
americké úřady, které je vymáhají, nebudou váhat
je uplatňovat na protisoutěžní aktivity v zahraničí.
Reciproční obchodování – jakákoli dohoda se
zákazníkem, typu „Budu od vás nakupovat, pokud
vy budete nakupovat ode mě“
Francisco Nakasato, 1700
13295-000 Itrevea Sao Paulo,
Brazílie
Telefonní číslo: +55 11 4593 9200
Evropa
Regionální centrála Pommer-
loch, Lucembursko
19 Route de Bastogne Pommer-
loch, Lucembursko, L-9638
Telefonní číslo: +352 269 050 35
Fax: +352 269 050 45
www.avient.com
http://www.avient.com
Rychlé rady: Antimonopolní zásady CO DĚLAT a CO NEDĚLAT
Antimonopolní kontrolní seznam
Ochrana před odvetou
Hlášení možných porušení
Závěr
Oblasti potenciálně dotčené antimonopolní problematikou
Porušení antimonopolních zákonů
Een Overzicht van de Amerikaanse Přehled antimonopolních zákonů USA
Přehled zásad
Horká linka pro etiku společnosti Avient
https://www.avient.com/sites/default/files/2024-10/Avient_CodeConduct_2024_VIT2.pdf
Hỏi đáp
Hỏi: Có người yêu cầu tôi để cửa mở để giúp họ vào một
trong các tòa nhà của Công ty.
Đây có phải là một vấn
đề không?
Chúng ta tiến hành kinh doanh theo
quy định của pháp luật với sự khuyến khích cạnh tranh mạnh mẽ
nhưng công bằng.
https://www.avient.com/sites/default/files/AVNT Q1 2023 Earnings Press Release.pdf
Rose
Vice President, Marketing and Communications
Avient Corporation
+1 440-930-3162
kyle.rose@avient.com
mailto:giuseppe.disalvo@avient.com
mailto:kyle.rose@avient.com
7
Attachment 1
Avient Corporation
Summary of Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
Three Months Ended
March 31,
2023 2022
Sales $ 845.7 $ 892.2
Operating Income 57.1 102.2
Net income from continuing operations attributable to Avient shareholders 20.8 64.4
Basic earnings per share from continuing operations attributable to Avient shareholders $ 0.23 $ 0.70
Diluted earnings per share from continuing operations attributable to Avient shareholders $ 0.23 $ 0.70
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and
diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items,
to assess performance and facilitate comparability of results.
Three Months Ended
March 31, 2023
Three Months Ended
March 31, 2022
Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS
Net income from continuing operations attributable to Avient shareholders $ 20.8 $ 0.23 $ 64.4 $ 0.70
Special items, after tax (Attachment 3) 22.3 0.24 6.4 0.07
Amortization expense, after-tax 15.1 0.16 10.8 0.12
Adjusted net income / EPS $ 58.2 $ 0.63 $ 81.6 $ 0.89
8
Attachment 2
Avient Corporation
Condensed Consolidated Statements of Income (Unaudited)
(In millions, except per share data)
Three Months Ended
March 31,
2023 2022
Sales $ 845.7 $ 892.2
Cost of sales 598.1 637.8
Gross margin 247.6 254.4
Selling and administrative expense 190.5 152.2
Operating income 57.1 102.2
Interest expense, net (28.8) (16.9)
Other income (expense), net 0.7 (0.6)
Income from continuing operations before income taxes 29.0 84.7
Income tax expense (7.7) (20.0)
Net income from continuing operations 21.3 64.7
(Loss) income from discontinued operations, net of income taxes (0.9) 19.8
Net income 20.4 84.5
Net income attributable to noncontrolling interests (0.5) (0.3)
Net income attributable to Avient common shareholders $ 19.9 $ 84.2
Earnings (loss) per share attributable to Avient common shareholders - Basic:
Continuing operations $ 0.23 $ 0.70
Discontinued operations (0.01) 0.22
Total $ 0.22 $ 0.92
Earnings (loss) per share attributable to Avient common shareholders - Diluted:
Continuing operations $ 0.23 $ 0.70
Discontinued operations (0.01) 0.21
Total $ 0.22 $ 0.91
Cash dividends declared per share of common stock $ 0.2475 $ 0.2375
Weighted-average shares used to compute earnings per common share:
Basic 91.0 91.5
Diluted 91.8 92.3
9
Attachment 3
Avient Corporation
Summary of Special Items (Unaudited)
(In millions, except per share data)
Special items (1)
Three Months Ended
March 31,
2023 2022
Cost of sales:
Restructuring costs, including accelerated depreciation $ (6.6) $ (4.4)
Environmental remediation costs (1.4) (2.0)
Reimbursement of previously incurred environmental costs — 0.6
Impact on cost of sales (8.0) (5.8)
Selling and administrative expense:
Restructuring, legal and other (15.7) 1.9
Acquisition related costs (3.4) (2.9)
Impact on selling and administrative expense (19.1) (1.0)
Impact on operating income (27.1) (6.8)
Other income (loss), net (0.2) 0.1
Impact on income from continuing operations before income taxes (27.3) (6.7)
Income tax expense (benefit) on above special items 6.9 1.8
Tax adjustments(2) (1.9) (1.5)
Impact of special items on net income from continuing operations $ (22.3) $ (6.4)
Diluted earnings per common share impact $ (0.24) $ (0.07)
Weighted average shares used to compute adjusted earnings per share:
Diluted 91.8 92.3
(1) Special items include charges related to specific strategic initiatives or financial restructuring such as: consolidation of operations; debt
extinguishment costs; costs incurred directly in relation to acquisitions or divestitures; employee separation costs resulting from personnel
reduction programs, plant realignment costs, executive separation agreements; asset impairments; settlement gains or losses and mark-to-
market adjustments associated with actuarial gains and losses on pension and other post-retirement benefit plans; environmental remediation
costs, fines, penalties and related insurance recoveries related to facilities no longer owned or closed in prior years; gains and losses on the
divestiture of operating businesses, gains and losses on facility or property sales or disposals; results of litigation, fines or penalties, where
such litigation (or action relating to the fines or penalties) arose prior to the commencement of the performance period; one-time, non-recurring
items; and the effect of changes in accounting principles or other such laws or provisions affecting reported results
Three Months Ended
March 31,
Reconciliation to Consolidated Statements of Income 2023 2022
Sales $ 845.7 $ 892.2
Gross margin - GAAP 247.6 254.4
Special items in gross margin (Attachment 3) 8.0 5.8
Adjusted gross margin $ 255.6 $ 260.2
Adjusted gross margin as a percent of sales 30.2 % 29.2 %
Operating income - GAAP 57.1 102.2
Special items in operating income (Attachment 3) 27.1 6.8
Adjusted operating income $ 84.2 $ 109.0
Adjusted operating income as a percent of sales 10.0 % 12.2 %
Three Months Ended
March 31,
Reconciliation to EBITDA and Adjusted EBITDA: 2023 2022
Net income from continuing operations – GAAP $ 21.3 $ 64.7
Income tax expense 7.7 20.0
Interest expense, net 28.8 16.9
Depreciation and amortization 50.5 37.6
EBITDA from continuing operations $ 108.3 $ 139.2
Special items, before tax 27.3 6.7
Depreciation and amortization included in special items (1.8) (2.1)
Adjusted EBITDA $ 133.8 $ 143.8
Adjusted EBITDA as a % of sales 15.8 % 16.1 %
NEWS RELEASE
Attachment 1
https://www.avient.com/sites/default/files/2021-04/versaflex-tpe-contact-lens-case-case-study.pdf
However, before making
the decision to switch from silicone to the Versaflex™
material, the company needed to feel confident that
it would recoup its capital, which included a $50,000
investment in new tooling, within 12 months.
Avient helped the customer calculate costs for the
12-month period.
Projections showed the
cost of a new tool would be recouped within months,
enabling the manufacturer to move forward with
confidence.
https://www.avient.com/sites/default/files/2020-12/resound-om-technical-bulletin_0.pdf
TECHNICAL BULLETIN
UV RESISTANCE
• UV testing: QUV-A Test, 0.68 @ 45C • Comparable results to traditional TPEs
reSound OM 5510-45N reSound OM 5510-60N
Bio-derived Content (%) 40% 50%
Hardness, Shore A 45 60
Delta E after 150 hrs. 0.22 0.23
Delta E after 300 hrs. 1.68 0.56
AGING – BONDING STRENGTH ONTO ABS
reSound OM 5520-55N Room Temperature 70C
1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks
Bio-derived Content (%) 49% 49% 49% 49% 49% 49% 49%
Hardness, Shore A 54 54 55 54 55 56
OM Substrate ABS ABS ABS ABS ABS ABS ABS
OM Avg.
Peel, PLI 12 19 23 20 19
reSound OM 5510 for PP
reSound OM 5510-60N Room Temperature 70C
1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks
Bio-derived Content (%) 50% 50% 50% 50% 50% 50% 50%
Hardness, Shore A 60 60 60 60 60 60 60
Specific Gravity 0.89 0.89 0.89 0.89 0.89 0.89 0.90
50% Modulus, PSI 247 241 244 251 234 244 240
100% Modulus, PSI 343 333 338 339 321 331 326
Tensile Strength, PSI 625 621 647 610 633 662 642
Elongation, % 306 314 309 313 312 315 315
Tear Strength, PLI 109 108 113 113 111 117 115
reSound OM 5520-55N Room Temperature 70C
1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks
Bio-derived Content (%) 49% 49% 49% 49% 49% 49% 49%
Hardness, Shore A 54 54 55 55 54 55 56
Specific Gravity 0.95 0.95 0.96 0.96 0.95 0.96 0.96
50% Modulus, PSI 258 256 256 265 266 271 257
100% Modulus, PSI 353 355 357 362 373 379 367
Tensile strength, PSI 637 615 637 669 651 674 642
Elongation, % 319 315 319 333 313 319 315
Tear Strength, PLI 146 136 133 142 137 138 141
reSound OM 5510-45N Room Temperature 70C
1 day 1 week 2 weeks 6 months 1 week 2 weeks 3 weeks
Bio-derived Content (%) 40% 40% 40% 40% 40% 40% 40%
Hardness, Shore A 45 46 47 46 46 45 45
Specific Gravity 0.88 0.89 0.89 0.89 0.89 0.89 0.90
50% Modulus, PSI 153 158 154 162 137 136 133
100% Modulus, PSI 251 259 259 261 226 222 218
Tensile Strength, PSI 438 481 451 495 417 470 486
Elongation, % 215 240 211 243 204 227 238
Tear Strength, PLI 84 81 87 82 83 85 84
AGING – PROPERTY RETENTION
• Tested at room temperature and 70° C for comparison • Hardness, tensile strength elongation and modulus
showed great retention
Overmolding onto PP
Overmolding onto ABS
RHEOLOGY
Suitable for injection molding and overmolding
1.0
10 100 1000 10000 100000
10.0
100.0
1000.0
reSound OM 5510-30N
reSound OM 5510-45N
reSound OM 5510-60N
reSound OM 5510-70N
Shear Rate, 1/s
C
ap
ill
ar
y
Vi
sc
os
it
y,
P
a*
s
1.0
10 100 1000 10000 100000
10.0
100.0
1000.0
reSound OM 5520-55N
Shear Rate, 1/s
C
ap
ill
ar
y
Vi
sc
os
it
y,
P
a*
s
Capillary viscosity at 200°C
Capillary viscosity at 200°C
reSound OM 5510 for PP
reSound OM 5520 for ABS
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/resources/Innovation_Day_-_May_2014_0.pdf
Patterson
President and Chief Executive Officer
PolyOne Corporation Page 27
Well Positioned for Revenue Growth
Addressable Market by Platform
$540
$215
$120
$40
$260
$525
($ millions)
Design/Service
Sustainable
Solutions
Surface
Modification
Lightweighting
Thermal
Control
Flame
Retardancy
$1.0 - $2.0 Billion of revenue
generated from new
products in 5 years
Gross margin on new products
exceed current gross margin by at
least 10 percentage points
World class vitality index of ≥ 35%
2018
PolyOne Corporation Page 28
Megatrends Aligned with Key End Markets
Decreasing
Dependence
on Fossil
Fuels
Protecting
the
Environment
Improving
Health and
Wellness
Megatrend End Markets
Globalizing
and
Localizing
Health &
Wellness
Transportation
Packaging
Consumer
PolyOne Corporation Page 29
2006 2013
Revenue
($ millions)
Health and Wellness Evolution
General
purpose
tubing
TPE applications
from GLS
Specialty tubing
Ergonomic
enhancements
Pre-certified
biocompatible
colorants
Highly
sophisticated
catheter and
drug delivery
components
Chemical and
heat
sterilizable
materials
Authentication
and protection
technologies
Addressing
wellness,
prevention,
diagnostic and
therapy changes in
healthcare setting
Healthcare
packaging
solutions
2006
2015 &
Beyond
$416
$105
PolyOne Corporation Page 30
Transportation Evolution
General
purpose
formulations
(bumpers, roof
racks)
Long fiber for
lightweighting
Thermal
management for
LED lighting
Thermoset
composite
pultrusions
Conductive
polymers for EMI
shielding
Formulations for
aerospace interiors
Thermoplastic
composites
High temperature
formulations for
aerospace
Expand 3D printing
capabilities
2006
2015 &
Beyond
2006 2013
Revenue
($ millions)
$709
$315
PolyOne Corporation Page 31
Packaging Evolution
Masterbatch
colors and PVC
packaging
materials
TPEs to enhance
brand appeal and
consumer
functionality
Liquid color and
additive
technologies to
extend shelf life,
preserve taste and
differentiate brands
Leveraging color,
additives and sheet
technology for
healthcare and
consumer packaging
solutions
2006
2015 &
Beyond
2006 2013
Revenue
($ millions)
$612
$260
PolyOne Corporation Page 32
Consumer Evolution
Commodity plastic
and masterbatch
color solutions
Engineered
materials to
enhance customer
appeal through
visual and
performance
improvements
Formulated metal-
to-polymer
conversion to
enhance
performance and
reduce
manufacturing
costs
Biopolymers &
composite materials
leveraging unique
color technology to
build brand identity
2006
2015 &
Beyond
2006 2013
Revenue
($ millions)
$394
$228
PolyOne Corporation Page 33
Interactive Display
Introduction
PolyOne Corporation Page 34
Interactive Displays
INNOVATION DISCUSSION LEADER TECHNOLOGIES M ARKETS
Polycast™ Bullet Resistant Sheet Aerospace
GlasArmor™ Ballistic Resistant Panels Security
reFlex™ Bio-Based Plasticizer Solutions
Wilflex™ Oasis Hydrate
InVisiO℠
Color Inspiration Forecast
In-Store Audits
OnColor™ Portfolio
Light Weighting
Thermal Management
Corrosion Resistance
Design Flexibility
Sustainability
Global Supply Chain
Ergonomics and Aesthetics
Consumer Appeal
9) Consume r Ele ctronics Solutions
Walter Ripple
General Manager
GLS
Personal Electronics
Wearable Electronics
Hand Held Devices
Portable Audio
7) M e tal Re place me nt Te chnology
Kurt Schuering
Vice President
Global Key Account Management
Aerospace
Transportation
Electrical & Electronics
Sporting and Shooting
8) M e dical De v ice Solutions
Dr.
VP / President
Performance Products & Solutions
Industrial
Sporting Goods
Consumer
Textiles
6) Color and De sign Se rv ice s
Fernando Sanchez
Director
Global Marketing
Packaging
Healthcare
Consumer
Automotive
3) 3D Printing
Cathy K.